rigosertib

Term ID

CHEBI:145417

Synonyms

(E)-ON 01910
[2-methoxy-5-({[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl}methyl)anilino]acetic acid
N-[2-methoxy-5-({[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl}methyl)phenyl]glycine
ON 01910
ON-01910
rigosertib
rigosertibum

(all 7)

Definition

An N-[2-methoxy-5-({[2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl}methyl)phenyl]glycine in which the double bond has E-configuration. It is a non-ATP-competitive inhibitor of PLK1 with an IC50 of 9 nM and exhibits anti-cancer properties.

References

(all 16)

Ontology

ChEBI ( EBI )

Relationships

is a type of: N-[2-methoxy-5-({[2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl}methyl)phenyl]glycine

N-[2-methoxy-5-({[2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl}methyl)phenyl]glycine Show first 5 Terms
has_role: antineoplastic agent apoptosis inducer EC 2.7.11.21 (polo kinase) inhibitor microtubule-destabilising agent

antineoplastic agent apoptosis inducer EC 2.7.11.21 (polo kinase) inhibitor microtubule-destabilising agent Show first 5 Terms
inverse is_conjugate_base_of: rigosertib(1-)

rigosertib(1-) Show first 5 Terms
is_conjugate_acid_of: rigosertib(1-)

rigosertib(1-) Show first 5 Terms

Phenotype

Phenotype resulting from rigosertib

Phenotype where environments contain rigosertib

Phenotype modified by environments containing rigosertib

Phenotype affecting rigosertib

Human Disease Model